GE HealthCare Launches MAGNUS Neuro Alliance to Advance Neuroscience Research

GE HealthCare has announced the formation of the MAGNUS Neuro Alliance, a collaborative research network aimed at advancing neuroscience research through the use of an ultra high-gradient head-only 3.0T MR system. This initiative, unveiled during the 5th High Performance Neuroimaging Symposium at the University of Iowa, will unite experts in neurology, radiology, psychiatry, and oncology to explore advanced MR imaging techniques and their applications in understanding the human brain.

Despite neurological disorders impacting over 3 billion individuals worldwide, MRI diagnostics have significant limitations, underscoring the need for enhanced MRI capabilities in clinical neurology. The MAGNUS system aims to address the shortcomings of conventional whole-body MR systems by providing improved performance for advanced anatomical, diffusion, and functional imaging research.

Kelly Londy, President and CEO of MR and Women’s Health at GE HealthCare, emphasized the importance of collaboration in the pursuit of groundbreaking scientific inquiries and methodologies. The alliance seeks to create a robust environment conducive to innovation and aims to translate research findings into meaningful healthcare outcomes.

The MAGNUS Neuro Alliance will foster collaboration among institutions such as Walter Reed University, University of Iowa, University of Wisconsin – Madison, Brigham and Women’s Hospital, West China Hospital of Sichuan University, King’s College London, and others. The research focuses will include:

• Deepening the understanding of the onset and progression of neurological diseases.
• Characterizing subtle alterations in brain structure and function associated with specific diseases.
• Developing novel imaging technologies and biomarkers.
• Innovating methods to detect and quantify disease-related changes in the brain.

Vince Magnotta, PhD, from the University of Iowa, noted that the consortium enables a collective approach to address complex questions in neuroscience, leveraging the unique capabilities of the MAGNUS scanner.

The ultra-high-gradient, head-only MRI system is designed to yield exceptional gradient performance and high-resolution imaging, facilitating research in various domains such as:

• Microstructural imaging at the cellular level.
• Monitoring neurodegenerative disease progression.
• Characterizing brain tumors and surrounding tissues.
• Identifying biomarkers in traumatic brain injury.
• Investigating sleep-related changes in brain structure and function.
• Assessing progression in multiple sclerosis.
• Exploring the neural correlates of psychiatric conditions.

Ultimately, the MAGNUS Neuro Alliance aims to push the boundaries of neuroscience research by facilitating innovative discoveries and enhancing understanding of neurological and psychiatric disorders.